APP and Alzheimer disease: Researchers have discovered that in transgenic mice that express the AD model protein APP/PS1, which is seen in AD, the intracellular bioavailability of Cu2+ in complex Cu2+−containing compounds such as bis‐(thiosemicarbazone) rises.